PH30242A - Serotonin 5htia agonists - Google Patents
Serotonin 5htia agonistsInfo
- Publication number
- PH30242A PH30242A PH43017A PH43017A PH30242A PH 30242 A PH30242 A PH 30242A PH 43017 A PH43017 A PH 43017A PH 43017 A PH43017 A PH 43017A PH 30242 A PH30242 A PH 30242A
- Authority
- PH
- Philippines
- Prior art keywords
- serotonin
- agonists
- 5htia agonists
- serotonin 5htia
- directed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57471090A | 1990-08-29 | 1990-08-29 | |
US07/735,700 US5189179A (en) | 1990-08-29 | 1991-07-30 | Serotonin 5ht1a agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30242A true PH30242A (en) | 1997-02-05 |
Family
ID=27076473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH43017A PH30242A (en) | 1990-08-29 | 1991-08-29 | Serotonin 5htia agonists |
Country Status (21)
Country | Link |
---|---|
US (3) | US5189179A (fr) |
EP (1) | EP0478954B1 (fr) |
JP (1) | JPH04270264A (fr) |
KR (1) | KR920004345A (fr) |
CN (1) | CN1030766C (fr) |
AT (1) | ATE197040T1 (fr) |
AU (1) | AU641535B2 (fr) |
CA (1) | CA2049803A1 (fr) |
DE (1) | DE69132450T2 (fr) |
DK (1) | DK0478954T3 (fr) |
ES (1) | ES2153346T3 (fr) |
FI (1) | FI914065A (fr) |
GR (1) | GR3035062T3 (fr) |
HU (1) | HU208955B (fr) |
IE (1) | IE913036A1 (fr) |
IL (1) | IL99306A (fr) |
NO (1) | NO175430C (fr) |
NZ (1) | NZ239521A (fr) |
PH (1) | PH30242A (fr) |
PT (1) | PT98800B (fr) |
TW (1) | TW200457B (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
USRE38506E1 (en) | 1991-10-04 | 2004-04-20 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
US6406859B1 (en) | 1992-01-08 | 2002-06-18 | Synaptic Pharmaceutical Corporation | DNA encoding a 5-HT 1F receptor and uses thereof |
GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
GB9304632D0 (en) * | 1993-03-06 | 1993-04-21 | Wyeth John & Brother Ltd | Amide derivatives |
FR2707294B1 (fr) * | 1993-07-06 | 1995-09-29 | Pf Medicament | Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine. |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
EP0894085B1 (fr) | 1996-03-29 | 2005-08-17 | Pfizer Inc. | Derives du benzyl(diene)-lactame, leur preparation et leur utilisation comme antagonistes/agonistes des recepteurs 5-ht1a- et/ou 5-ht1d |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US6121307A (en) * | 1998-04-08 | 2000-09-19 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
CA2327360A1 (fr) * | 1998-04-08 | 1999-10-14 | Richard Eric Mewshaw | Derives d'amine indol-3-yl-cyclhexyle utilises dans le traitement de la depression (antagonistes du recepteur 5-ht1) |
AU3479299A (en) * | 1998-04-08 | 1999-10-25 | American Home Products Corporation | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
CA2327359A1 (fr) * | 1998-04-08 | 1999-10-14 | Wyeth | N-aryloxyethyl-indoly-alkylamines utilisees pour le traitement de la depression (principes actifs de recepteurs du type 5-ht1a) |
US6150533A (en) * | 1998-04-08 | 2000-11-21 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
US7588029B2 (en) * | 2000-03-21 | 2009-09-15 | Fisher & Paykel Healthcare Limited | Humidified gases delivery apparatus |
AU2002325712C1 (en) | 2001-08-30 | 2008-07-31 | Stem Cell Therapeutics Inc. | Differentiation of neural stem cells and therapeutic use theeof |
AR036401A1 (es) * | 2001-09-14 | 2004-09-08 | Stem Cell Therapeutics Inc | Incremento de la cantidad de celulas madre neuronales inducido por prolactina. |
US20030054551A1 (en) * | 2001-09-18 | 2003-03-20 | Stem Cell Therapeutics Inc. | Effect of growth hormone and IGF-1 on neural stem cells |
EP1546198A1 (fr) * | 2002-07-31 | 2005-06-29 | Stem Cell Therapeutics Inc. | Procede d'amelioration de la proliferation, de la differentiation et de la survie de cellules souches neurales au moyen du polypeptide d'activation d'adenylate cyclase hypophysaire (pacap) |
ATE546134T1 (de) * | 2002-12-26 | 2012-03-15 | Pozen Inc | Mehrschichtige dosierformen enthaltend naproxen und triptane |
KR20060015641A (ko) * | 2003-06-06 | 2006-02-17 | 글락소 그룹 리미티드 | 트립탄 및 nsaid를 포함하는 조성물 |
WO2005018541A2 (fr) * | 2003-07-11 | 2005-03-03 | Pharmacia Corporation | Compositions renfermant un inhibiteur selectif de la cyclo-oxygenase-2 et un agent modulant la serotonine destinees au traitement de lesions du systeme nerveux central |
US20070111932A1 (en) * | 2003-07-31 | 2007-05-17 | Stem Cell Therapeutics Inc. | Method of enhancing and/or inducing neuronal migration using erythropoietin |
EP1660079A2 (fr) * | 2003-08-22 | 2006-05-31 | Pharmacia Corporation | Compositions d'un inhibiteur selectif de la cyclo-oxygenase 2 et d'un agent de modulation de la serotonine pour le traitement de la neoplasie |
CN1325673C (zh) * | 2003-12-30 | 2007-07-11 | 上海交通大学 | 利用废旧紫铜生产无氧铜的装置 |
US7846898B2 (en) * | 2004-02-13 | 2010-12-07 | Stem Cell Therapeutics Corp. | Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
JP2008545650A (ja) | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファミド誘導体の製造方法 |
JP2009509943A (ja) | 2005-09-27 | 2009-03-12 | ステム セル セラピューティクス コーポレイション | プロラクチンにより制御される乏突起膠細胞前駆体細胞の増殖 |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
AU2007229301B2 (en) * | 2006-03-17 | 2013-08-01 | Stem Cell Therapeutics Corp. | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
TW200812573A (en) | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
MX2011000090A (es) | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida. |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN111116451A (zh) * | 2020-01-16 | 2020-05-08 | 宁波大学 | 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2725386A (en) * | 1953-02-13 | 1955-11-29 | Fond Emanuele Paterno | 2-(1, 4-benzodioxan) methyl derivatives of amino-lower fatty acid amides and preparation thereof |
FR2463765A1 (fr) * | 1979-08-17 | 1981-02-27 | Clin Midy | Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire |
US4684739A (en) * | 1980-12-15 | 1987-08-04 | Mitsubishi Chemical Industries Limited | Alkylenedioxybenzene derivatives and acid addition salts thereof |
US4614807A (en) * | 1984-10-04 | 1986-09-30 | Eli Lilly And Company | 6,7-dihalomelatonins |
ATE65084T1 (de) * | 1986-06-26 | 1991-07-15 | Ciba Geigy Ag | Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen. |
DE3642497A1 (de) * | 1986-12-12 | 1988-06-23 | Hoechst Ag | Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte |
US4956382A (en) * | 1987-02-07 | 1990-09-11 | Pfizer Inc. | Sulfonamide anti-arrhythmic agents |
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5120758A (en) * | 1991-02-08 | 1992-06-09 | Ciba-Geigy Corporation | Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors |
-
1991
- 1991-07-30 US US07/735,700 patent/US5189179A/en not_active Expired - Fee Related
- 1991-08-23 AU AU82664/91A patent/AU641535B2/en not_active Ceased
- 1991-08-23 CA CA002049803A patent/CA2049803A1/fr not_active Abandoned
- 1991-08-23 NZ NZ239521A patent/NZ239521A/xx unknown
- 1991-08-26 IL IL9930691A patent/IL99306A/en unknown
- 1991-08-27 KR KR1019910014843A patent/KR920004345A/ko not_active Application Discontinuation
- 1991-08-28 ES ES91114456T patent/ES2153346T3/es not_active Expired - Lifetime
- 1991-08-28 EP EP91114456A patent/EP0478954B1/fr not_active Expired - Lifetime
- 1991-08-28 DK DK91114456T patent/DK0478954T3/da active
- 1991-08-28 PT PT98800A patent/PT98800B/pt not_active IP Right Cessation
- 1991-08-28 IE IE303691A patent/IE913036A1/en not_active Application Discontinuation
- 1991-08-28 FI FI914065A patent/FI914065A/fi not_active Application Discontinuation
- 1991-08-28 HU HU912810A patent/HU208955B/hu not_active IP Right Cessation
- 1991-08-28 NO NO913384A patent/NO175430C/no unknown
- 1991-08-28 AT AT91114456T patent/ATE197040T1/de not_active IP Right Cessation
- 1991-08-28 DE DE69132450T patent/DE69132450T2/de not_active Expired - Fee Related
- 1991-08-29 TW TW080106873A patent/TW200457B/zh active
- 1991-08-29 PH PH43017A patent/PH30242A/en unknown
- 1991-08-29 CN CN91108614A patent/CN1030766C/zh not_active Expired - Fee Related
- 1991-08-29 JP JP3242328A patent/JPH04270264A/ja active Pending
-
1992
- 1992-10-16 US US07/962,434 patent/US5387604A/en not_active Expired - Fee Related
-
1994
- 1994-10-07 US US08/319,916 patent/US5559143A/en not_active Expired - Fee Related
-
2000
- 2000-12-13 GR GR20000402750T patent/GR3035062T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU8266491A (en) | 1992-03-05 |
CA2049803A1 (fr) | 1992-03-01 |
AU641535B2 (en) | 1993-09-23 |
US5387604A (en) | 1995-02-07 |
CN1030766C (zh) | 1996-01-24 |
EP0478954B1 (fr) | 2000-10-18 |
GR3035062T3 (en) | 2001-03-30 |
FI914065A0 (fi) | 1991-08-28 |
FI914065A (fi) | 1992-03-01 |
KR920004345A (ko) | 1992-03-27 |
NO913384L (no) | 1992-03-02 |
US5189179A (en) | 1993-02-23 |
EP0478954A1 (fr) | 1992-04-08 |
TW200457B (fr) | 1993-02-21 |
IE913036A1 (en) | 1992-03-11 |
DE69132450D1 (de) | 2000-11-23 |
NO913384D0 (no) | 1991-08-28 |
HUT59092A (en) | 1992-04-28 |
NO175430C (no) | 1994-10-12 |
PT98800B (pt) | 1999-01-29 |
IL99306A0 (en) | 1992-07-15 |
IL99306A (en) | 1995-03-30 |
CN1059717A (zh) | 1992-03-25 |
PT98800A (pt) | 1992-08-31 |
NO175430B (no) | 1994-07-04 |
ATE197040T1 (de) | 2000-11-15 |
US5559143A (en) | 1996-09-24 |
JPH04270264A (ja) | 1992-09-25 |
DK0478954T3 (da) | 2001-01-08 |
DE69132450T2 (de) | 2001-05-03 |
NZ239521A (en) | 1993-07-27 |
ES2153346T3 (es) | 2001-03-01 |
HU208955B (en) | 1994-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30242A (en) | Serotonin 5htia agonists | |
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
MX9203338A (es) | Nuevos derivados del oxico a_nor-esteroide-3-carboxilico. | |
NO901392D0 (no) | Immunomodulerende azaspiraner. | |
GR3023040T3 (en) | Substituted indoles as anti-aids pharmaceuticals | |
IL89921A (en) | 1,3-dioxolane derivatives and pharmaceutical compositions containing the same | |
ES2107998T3 (es) | Alcanolaminas derivatizadas como agentes cardiovasculares. | |
DK0406211T3 (da) | Fucosidase-inhibitorer | |
AP8800109A0 (en) | "Heterocyclic insecticides". | |
PT81933A (en) | Process for preparing improved antiinflammatory compositions containing pyroxicam and inositol | |
DE69328774D1 (de) | Herstellung von körnigen alkalimetallborat-zusammensetzungen | |
HUT64517A (en) | Process for producing 1-piperidinyl-alkanoyl-aryl-sulfonamide derivatives and pharmaceutical compositions containing them | |
GR3019047T3 (en) | Heterocyclic-NMDA antagonists. | |
DK0673913T3 (da) | Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler | |
DE3781986D1 (de) | Substituierte chinoxaline. | |
ES2027507A6 (es) | Procedimiento de preparacion de derivados selenofenicos. | |
ATE42280T1 (de) | Derivate des bicyclo(3.3.0>oktans und ihre herstellung. | |
DE69002027D1 (de) | (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid. |